Canadian Association of Neuroscience Review: Axonal regeneration in the peripheral and central nervous systems - Current issues and advances

Canadian Journal of Neurological Sciences

Volumn 31, Issue 2, 2004, Pages 142-156

  Fenrich, Keith ^a   Gordon, Tessa ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; FORSKOLIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MEMBRANE PROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NERVE GROWTH FACTOR; NEUROTROPHIN 3; PROTEIN NOGO; PROTEIN NOGO A; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL MODEL; AXONAL INJURY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GLIA CELL; NERVE DEGENERATION; NERVE FIBER REGENERATION; NERVE INJURY; NONHUMAN; OLIGODENDROGLIA; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REVIEW; SCHWANN CELL; TISSUE TRANSPLANTATION;

EID: 2642547604     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100053798     Document Type: Review

References (214)

1. Fu SY, Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 1997; 14:67-116.
2. Boyd JG, Gordon T. Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Mol Neurobiol 2003; 27:277-324.
3. Kline DG, Hudson AR. Nerve Injuries: Operative Results for Major Nerve Injuries, Entrapments and Tumors. Philadelphia: 1995.
4. Kury P, Stoll G, Muller HW. Molecular mechanisms of cellular interactions in peripheral nerve regeneration. Curr Opin Neurol 2001; 14:635-639.
5. Sulaiman OAR, Boyd JG, Gordon T. Regeneration in the peripheral system of mammals. Neuroglia 2003; In press.
6. Fawcett J. Repair of spinal cord injuries: where are we, where are we going? Spinal Cord 2002; 40:615-623.
7. Bunge MB. Bridging areas of injury in the spinal cord. Neuroscientist 2001; 7:325-339.
8. Horner PJ, Gage FH. Regenerating the damaged central nervous system. Nature 2000; 407:963-970.
9. Fouad K, Dietz V, Schwab ME. Improving axonal growth and functional recovery after experimental spinal cord injury by neutralizing myelin associated inhibitors. Brain Res Brain Res Rev 2001; 36:204-212.
10. Edgerton VR, Roy RR. Paralysis recovery in humans and model systems. Curr Opin Neurobiol 2002; 12:658-667.
11. David S, Lacroix S. Molecular approaches to spinal cord repair. Ann Rev Neurosci 2003.
12. Klusman I, Schwab ME. Axonal regeneration in the central nervous system of mammals. Neuroglia 2003; In press.
13. Goldberg JL, Barres BA. The relationship between neuronal survival and regeneration. Ann Rev Neurosci 2000; 23:579-612.
14. Steward O, Zheng B, Tessier-Lavigne M. False resurrections: distinguishing regenerated from spared axons in the injured central nervous system. J Comp Neurol 2003; 459:1-8.
15. Selzer ME. Promotion of axonal regeneration in the injured CNS. Lancet Neurol 2003; 2:157-166.
16. Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibers. Phil Transact Royal Soc London 1850; 140:423-429.
17. Cajal Ramon Y. Degeneration and Regeneration of the Nervous System. New York: Hafner Publishing Co, 1959.
18. Stoll G, Jander S, Myers RR. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation. J Peripher Nerv Syst 2002; 7:13-27.
19. Vrbova G, Gordon T, Jones R. Nerve-Muscle Interaction. 2nd ed; London: Chapman and Hall, 1995.
20. Stoll G, et al. Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol 1989; 18:671-683.
21. Schlaepfer WW, Bunge RP. Effects of calcium ion concentration on the degeneration of amputated axons in tissue culture. J Cell Biol 1973; 59:456-470.
22. George EB, Glass JD, Griffin JW. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neuroscience 1995; 15:6445-6452.
23. LeBlanc AC, Poduslo JF. Axonal modulation of myelin gene expression in the peripheral nerve. J Neurosci Res 1990; 26:317-326.
24. Cohan CS. Depolarization-induced changes in neurite elongation and intracellular Ca2+ in isolated Helisoma neurons. J Neurobiol 1992; 23:983-996.
25. Hall SM. The biology of chronically denervated Schwann cells. Ann NY Acad Sci 1999; 883:215-233.
26. Liu HM, Yang LH, Yang YJ. Schwann cell properties: 3. C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration. J Neuropathol Exp Neurol 1995; 54:487-496.
27. Hirata K, Kawabuchi M. Myelin phagocytosis by macrophages and nonmacrophages during Wallerian degeneration. Microsc Res Tech 2002; 57:541-547.
28. Anton ES, et al. Nerve growth factor and its low-affinity receptor promote Schwann cell migration. Proc Natl Acad Sci USA 1994; 91:2795-2799.
29. Bruck W. The role of macrophages in Wallerian degeneration. Brain Pathol 1997; 7:741-752.
30. Avellino AM, et al. Differential macrophage responses in the peripheral and central nervous system during wallerian degeneration of axons. Exp Neurol 1995; 136:183-198.
31. Perry VH, Brown MC, Gordon S. The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. J Exp Med 1987; 165:1218-1223.
32. Reichert F, Saada A, Rotshenker S. Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: phagocytosis and the galactose-specific lectin MAC-2. J Neuroscience 1994; 14:3231-3245.
33. Tofaris GK, et al. Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neuroscience 2002; 22:6696-6703.
34. Liefner M, et al. The role of TNF-alpha during Wallerian degeneration. J Neuroimmunol 2000; 108:147-152.
35. Vrbova G, Gordon T, Jones R. Nerve-Muscle Interaction. 2nd ed. London: Chapman and Hall, 1995.
36. Martini R. Expression and functional roles of neural cell surface molecules and extracellular matrix components during development and regeneration of peripheral nerves. J Neurocytol 1994; 23:1-28.
37. Tang S, et al. Soluble myelin-associated glycoprotein (MAG) found in vivo inhibits axonal regeneration. Mol Cell Neurosci 1997; 9:333-346.
38. Filbin MT. The Muddle with MAG. Mol Cell Neurosci 1996; 8:84-92.
39. Filbin MT. Myelin-associated glycoprotein: a role in myelination and in the inhibition of axonal regeneration? Curr Opin Neurobiol 1995; 5:588-595.
40. Shamash S, Reichert F, Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J Neurosci 2002; 22:3052-3060.
41. Gillen C, Jander S, Stoll G. Sequential expression of mRNA for proinflammatory cytokines and interleukin-10 in the rat peripheral nervous system: comparison between immune-mediated demyelination and Wallerian degeneration. J Neurosci Res 1998; 51:489-496.
42. Stoll G, et al. Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J Neuroimmunol 1993; 45:175-182.
43. Oppenhheim JJ, Feldman M. Introduction to the role of cytokines in innate and defense and adaptive immunity. In: Oppenheim JJ, Feldman M, (Eds). Cytokines Reference. New York: Academic. 2001;3-20.
44. Gordon T. Dependence of peripheral nerves on their target organs. In Bumstock G, Vrbova G, O'Brien R (Eds). Somatic and Autonomic Nerve-Muscle Interactions. New York, NY: Elsevier Science Publishers, 1983;289-325.
45. Kreutzberg GW. Principles of neuronal regeneration. Acta Neurochir Suppl 1996; 66:103-106.
46. Kreutzberg GW. Reaction of the cell body to axonal damage. In: Waxman SG, Kocsis JD, Stys PK, (Eds). The Axon. New York, Oxford: Oxford University Press, 1995;355-374.
47. Bulsara KR, et al. A new millenium for spinal cord regeneration: growth-associated genes. Spine 2002; 27:1946-1949.
48. Bomze HM, et al. Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons. Nat Neurosci 2001; 4:38-43.
49. Strittmatter SM, Igarashi M, Fishman MC. GAP-43 amino terminal peptides modulate growth cone morphology and neurite outgrowth. J Neuroscience 1994; 14:5503-5513.
50. Igarashi M, et al. Ligand-induced growth cone collapse: amplification and blockade by variant GAP-43 peptides. J Neuroscience 1995; 15:5660-5667.
51. Tetzlaff W, et al. Retrograde changes in transglutaminase activity after peripheral nerve injuries. Brain Res 1988; 445:142-146.
52. Tetzlaff W, et al. Response of facial and rubrospinal neurons to axotomy: changes in mRNA expression for cytoskeletal proteins and GAP-43. J Neurosci 1991; 11:2528-2544.
53. Gordon T, et al. Axotomy-induced changes in rabbit hindlimb nerves and the effects of chronic electrical stimulation. J Neurosci 1991; 11:2157-2169.
54. Tetzlaff W, et al. Reductions in motoneuronal neurofilament synthesis by successive axotomies: a possible explanation for the conditioning lesion effect on axon regeneration. Exp Neurol 1996; 139:95-106.
55. Rahmatullah M, et al. Synergistic regulation of Schwann cell proliferation by heregulin and forskolin. Mol Cell Biol 1998; 18:6245-6252.
56. Carroll SL, et al. Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration. J Neurosci 1997; 17:1642-1659.
57. Sulaiman O, Boyd JG, Gordon T. Regeneration in the peripheral nervous system of mammals. In Kettermann H, Ransom B, (Eds). Neuroglia. 2nd ed. 2003 (In press).
58. Ide C. Peripheral nerve regeneration. Neurosci Res 1996; 25:101-121.
59. Guenard V, et al. Onion bulb cells in mice deficient for myelin genes share molecular properties with immature, differentiated nonmyelinating, and denervated Schwann cells. Glia 1996; 18:27-38.
60. Mirsky R, Jessen KR. The neurobiology of Schwann cells. Brain Pathol 1999; 9:293-311.
61. Scherer SS, Salzer JL. Axon-Schwann cell interactions during peripheral nerve degeneration and regeneration. Glial Cell Development: Basic Principles and Clinical Relevance 1996;169-196.
62. Scherer SS, Arroyo EJ. Recent progress on the molecular organization of myelinated axons. J Peripher Nerv Syst 2002; 7:1-12.
63. Markus A, Patel TD, Snider WD. Neurotrophic factors and axonal growth. Curr Opin Neurobiol 2002; 12:523-531.
64. Funakoshi H, et al. Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J Cell Biol 1993; 123:455-465.
65. Hoke A, et al. A decline in glial cell-line-derived neurotrophic factor expression is associated with impaired regeneration after long-term Schwann cell denervation. Exp Neurol 2002; 173:77-85.
66. Ito Y, et al. Differential temporal expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha and gp130) in injured peripheral nerves. Brain Res 1998; 793:321-327.
67. Meyer M, et al. Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for the regulation of BDNF and NGF mRNA. J Cell Biol 1992; 119:45-54.
68. Naveilhan P, ElShamy WM, Emfors P. Differential regulation of mRNAs for GDNF and its receptors Ret and GDNFR alpha after sciatic nerve lesion in the mouse. Eur J Neurosci 1997; 9:1450-1460.
69. Seniuk N, et al. Decreased synthesis of ciliary neurotrophic factor in degenerating peripheral nerves. Brain Res 1992; 572:300-302.
70. Bolin LM, et al. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem 1995; 64:850-858.
71. Griffin JW, George R, Ho T. Macrophage systems in peripheral nerves. A review. J Neuropathol Exp Neurol 1993; 52:553-560.
72. Araki T, Nagarajan R, Milbrandt J. Identification of genes induced in peripheral nerve after injury. Expression profiling and novel gene discovery. J Biol Chem 2001; 276:34131-34141.
73. George R, Griffin JW. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp Neurol 1994; 129:225-236.
74. Rapalino O, et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 1998; 4:814-821.
75. Stoll G, Muller HW. Nerve injury, axonal degeneration and neural regeneration: basic insights. Brain Pathol 1999; 9:313-325.
76. Bandtlow CE, Schwab ME. NI-35/250/nogo-a: a neurite growth inhibitor restricting structural plasticity and regeneration of nerve fibers in the adult vertebrate CNS. Glia 2000; 29:175-181.
77. Qiu J, Cai D, Filbin MT. Glial inhibition of nerve regeneration in the mature mammalian CNS. Glia 2000; 29:166-174.
78. Filbin MT. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 2003; 4:703-713.
79. Mukhopadhyay G, et al. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 1994; 13:757-767.
80. Nakajima K, Kohsaka S. Microglia: activation and their significance in the central nervous system. J Biochem (Tokyo) 2001; 130:169-175.
81. Leskovar A, et al. The macrophage in acute neural injury: changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems. J Exp Biol 2000; 203(12):1783-1795.
82. Jander S, Lausberg F, Stoll G. Differential recruitment of CD8+ macrophages during Wallerian degeneration in the peripheral and central nervous system. Brain Pathol 2001; 11:27-38.
83. Bush MS, et al. Expression of a developmentally regulated, phosphorylated isoform of microtubule-associated protein 1B in regenerating axons of the sciatic nerve. Neuroscience 1996; 73:553-563.
84. Caroni P, Aigner L, Schneider C. Intrinsic neuronal determinants locally regulate extrasynaptic and synaptic growth at the adult neuromuscular junction. J Cell Biol 1997; 136:679-692.
85. Caroni P. Intrinsic neuronal determinants that promote axonal sprouting and elongation. Bioessays 1997; 19:767-775.
86. Caroni P. Overexpression of growth-associated proteins in the neurons of adult transgenic mice. J Neurosci Methods 1997; 71:3-9.
87. De la Monte SM, et al. GAP-43 gene expression during development: persistence in a distinctive set of neurons in the mature central nervous system. Brain Res Dev Brain Res 1989; 46:161-168.
88. Herdegen T, Skene P, Bahr M. The c-Jun transcription factor-bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci 1997; 20:227-231.
89. Jacobson RD, Virag I, Skene JH. A protein associated with axon growth, GAP-43, is widely distributed and developmentally regulated in rat CNS. J Neurosci 1986; 6:1843-1855.
90. Simkowitz P, Ellis L, Pfenninger KH, Membrane proteins of the nerve growth cone and their developmental regulation. J Neurosci 1989; 9:1004-1017.
91. Skene JH, et al. A protein induced during nerve growth (GAP-43) is a major component of growth-cone membranes. Science 1986; 233:783-786.
92. Skene JH. Axonal growth-associated proteins. Annu Rev Neurosci 1989; 12:127-156.
93. Fernandes KJ, et al. Influence of the axotomy to cell body distance in rat rubrospinal and spinal motoneurons: differential regulation of GAP-43, tubulins, and neurofilament-M. J Comp Neurol 1999; 414:495-510.
94. Hiebert GW, et al. Immunological myelin disruption does not alter expression of regeneration-associated genes in intact or axotomized rubrospinal neurons. Exp Neurol 2000; 163:149-156.
95. Kwon BK, Tetzlaff W. Spinal cord regeneration: from gene to transplants. Spine 2001; 26:13-22.
96. Plunet W, Kwon BK, Tetzlaff W. Promoting axonal regeneration in the central nervous system by enhancing the cell body response to axotomy. J Neurosci Res 2002; 68:1-6.
97. Doster SK, et al. Expression of the growth-associated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron 1991; 6:635-647.
98. Benfey M, Aguayo AJ. Extensive elongation of axons from rat brain into peripheral nerve grafts. Nature 1982; 296:150-152.
99. David S, Aguayo AJ. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science 1981; 214:931-933.
100. Richardson PM, McGuinness UM, Aguayo AJ. Axons from CNS neurons regenerate into PNS grafts. Nature 1980; 284:264-265.
101. Vidal-Sanz M, et al. Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat. J Neurosci 1987; 7:2894-2909.
102. So KF, Aguayo AJ. Lengthy regrowth of cut axons from ganglion cells after peripheral nerve transplantation into the retina of adult rats. Brain Res 1985; 328:349-354.
103. Paino CL, et al. Regrowth of axons in lesioned adult rat spinal cord: promotion by implants of cultured Schwann cells. J Neurocytol 1994; 23:433-452.
104. Savio T, Schwab ME. Lesioned corticospinal tract axons regenerate in myelin-free rat spinal cord. Proc Natl Acad Sci USA 1990; 87:4130-4133.
105. Liu Y, et al. Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J Neurosci 1999; 19:4370-4387.
106. Tuszynski MH, Mafong E, Meyer S. Central infusions of brain-derived neurotrophic factor and neurotrophin-4/5, but not nerve growth factor and neurotrophin-3, prevent loss of the cholinergic phenotype in injured adult motor neurons. Neuroscience 1996; 71:761-771.
107. Weidner N, et al. Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1. J Comp Neurol 1999; 413:495-506.
108. Hiebert GW, et al. Brain-derived neurotrophic factor applied to the motor cortex promotes sprouting of corticospinal fibers but not regeneration into a peripheral nerve transplant. J Neurosci Res 2002; 69:160-168.
109. Mohajeri MH, Figlewicz DA, Bohn MC. Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum Gene Ther 1999; 10:1853-1866.
110. Tuszynski MH, Gage FH. Bridging grafts and transient nerve growth factor infusions promote long-term central nervous system neuronal rescue and partial functional recovery. Proc Natl Acad Sci U S A 1995; 92:4621-4625.
111. Lu P, Blesch A, Tuszynski MH. Neurotrophism without neurotropism: BDNF promotes survival but not growth of lesioned corticospinal neurons. J Comp Neurol 2001; 436:456-470.
112. Caroni P, Schwab ME. Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading. J Cell Biol 1988; 106:1281-1288.
113. Chen Y, Swanson RA. Astrocytes and brain injury. J Cereb Blood Flow Metab 2003; 23:137-149.
114. McKeon RJ, et al. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J Neurosci 1991; 11:3398-3411.
115. Jones LL, Margolis RU, Tuszynski MH. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 2003; 182:399-411.
116. Jakeman LB, Reier PJ. Axonal projections between fetal spinal cord transplants and the adult rat spinal cord: a neuroanatomical tracing study of local interactions. J Comp Neurol 1991; 307:311-334.
117. Kruger S, et al. Three morphologically distinct types of interface develop between adult host and fetal brain transplants: implications for scar formation in the adult central nervous system. J Comp Neurol 1986; 249:103-116.
118. Rier PJ, Stensass LJ, Guth L. The astrocytic scar as an impediment to regeneration in the CNS. In: Kao CC, Burge RP, Reter PJ, (Eds). Spinal Cord Reconstruction. New York: Raven Press, 1983;163-195.
119. Rudge JS, Silver J. Inhibition of neurite outgrowth on astroglial scars in vitro. J Neurosci 1990; 10:3594-3603.
120. Bandtlow CE, Zimmermann DR. Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 2000; 80:1267-1290.
121. Davies SJ, et al. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 1999; 19:5810-5822.
122. Fawcett JW, Asher RA. The glial scar and central nervous system repair. Brain Res Bull 1999; 49:377-391.
123. Caroni P, Schwab ME. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1988; 1:85-96.
124. Schnell L, Schwab ME. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 1990; 343:269-272.
125. Bregman BS, et al. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 1995; 378:498-501.
126. Chen MS, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000; 403:434-439.
127. GrandPre T, et al. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000; 403:439-444.
128. Prinjha R, et al. Inhibitor of neurite outgrowth in humans. Nature 2000; 403:383-384.
129. Pot C, et al. Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury. J Cell Biol 2002; 159:29-35.
130. Oertle T, Schwab ME. Nogo and its partners. Trends Cell Biol 2003; 13:187-194.
131. Huber AB, et al. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 2002; 22:3553-3567.
132. Hunt D, Coffin RS, Anderson PN. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review. J Neurocytol 2002; 31:93-120.
133. Fournier AE, GrandPre T, Strittmatter SM. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 2001; 409:341-346.
134. Wang KC, et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 2002; 417:941-944.
135. Wang KC, et al. P75 interacts with the Nogo receptor as a coreceptor for Nogo, MAG and OMgp. Nature 2002; 420:74-78.
136. Josephson A, et al. NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury. Exp Neurol 2001; 169:319-328.
137. Neumann S, Woolf CJ. Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury. Neuron 1999; 23:83-91.
138. Neumann S, et al. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron 2002; 34:885-893.
139. Pot C, et al. Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury. J Cell Biol 2002; 159:29-35.
140. Simonen M, et al. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 2003; 38:201-211.
141. Zheng B, et al. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron 2003; 38:213-224.
142. Kim JE, et al. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 2003; 38:187-199.
143. Woolf CJ. No Nogo: now where to go? Neuron 2003; 38:153-156.
144. Josephson A, et al. Nogo-receptor gene activity: cellular localization and developmental regulation of mRNA in mice and humans. J Comp Neurol 2002; 453:292-304.
145. Hunt D, et al. Nogo receptor mRNA expression in intact and regenerating CNS neurons. Mol Cell Neurosci 2002; 20:537-552.
146. Bartsch U, Kirchhoff F, Schachner M. Immunohistological localization of the adhesion molecules L1, N-CAM, and MAG in the developing and adult optic nerve of mice. J Comp Neurol 1989; 284:451-462.
147. Favilla JT, et al. Myelin-associated glycoprotein (MAG) distribution in human central nervous tissue studied immunocytochemically with monoclonal antibody. J Neuroimmunol 1984; 6:19-30.
148. deBellard ME, et al. Myelin-associated glycoprotein inhibits axonal regeneration from a variety of neurons via interaction with a sialoglycoprotein. Mol Cell Neurosci 1996; 7:89-101.
149. McKerracher L, et al. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 1994; 13:805-811.
150. Shibata A, et al. Unique responses of differentiating neuronal growth cones to inhibitory cues presented by oligodendrocytes. J Cell Biol 1998; 142:191-202.
151. Song H, et al. Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science 1998; 281: 1515-1518.
152. Cai D, et al. Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J Neurosci 2001; 21:4731-4739.
153. Domeniconi M, et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 2002; 35:283-290.
154. Yamaghita T, Higuchi H, Tohyama M. The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J Cell Biol 2002; 157:565-570.
155. Niederost B, et al. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci 2002; 22:10368-10376.
156. Wong ST, et al. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci 2002; 5:1302-1308.
157. Kaplan DR, Miller FD. Axon growth inhibition: signals from the p75 neurotrophin receptor. Nat Neurosci 2003; 6:435-436.
158. Mikol DD, Gulcher JR, Stefansson K. The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J Cell Biol 1990; 110:471-479.
159. Quarles RH. Glycoproteins of myelin sheaths. J Mol Neurosci 1997; 8:1-12.
160. Spencer T, et al. New roles for old proteins in adult CNS axonal regeneration. Curr Opin Neurobiol 2003; 13:133-139.
161. Eccles JC, Sherrington CS. Numbers and contraction values of individual motor units examined in some muscles of the limb. Proc R Soc B 1930; 106:326-357.
162. Sunderland S. Nerve Injury and Repair. Edinburgh: Churchill Livingstone, 1991.
163. Lundborg G. Nerve Injury and Repair. Edinburgh: Churchill Livingstone, 1988.
164. Cajal Ramon Y. Degeneration and Regeneration of the Nervous System. New York: Hafner publishing Co, 1959.
165. You S, et al. The expression of the low affinity nerve growth factor receptor in long-term denervated Schwann cells, Glia 1997; 20:87-100.
166. Hall SM. The biology of chronically denervated Schwann cells. Ann N Y Acad Sci 1999; 883:215-233.
167. Ng CE, Tang BL. Nogos and the Nogo-66 receptor: factors inhibiting CNS neuron regeneration. J Neurosci Res 2002; 67:559-565.
168. Plunet W, Kwon BK, Tetzlaff W. Promoting axonal regeneration in the central nervous system by enhancing the cell body response to axotomy. J Neurosci Res 2002; 68:1-6.
169. Boyd JG, Gordon T. The neurotrophin receptors, trkB and p75, differentially regulate motor axonal regeneration. J Neurobiol 2001; 49:314-325.
170. Fu SY, Gordon T. Contributing factors to poor functional recovery after delayed nerve repair: prolonged axotomy. J Neurosci 1995; 15:3876-3885.
171. Boyd JG, Gordon T. A dose-dependent facilitation and inhibition of peripheral nerve regeneration by brain-derived neurotrophic factor, Eur J Neurosci 2002; 15:613-626.
172. Cisterni C, et al. Efficient gene transfer and expression of biologically active glial cell line-derived neurotrophic factor in rat motoneurons transduced with lentiviral vectors. J Neurochem 2000; 74:1820-1828.
173. Hottinger AF, et al. Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus. J Neurosci 2000; 20:5587-5593.
174. Lee M, et al. FK506 promotes functional recovery in crushed rat sciatic nerve. Muscle Nerve 2000; 23:633-640.
175. Sulaiman OA, et al. FK506 increases peripheral nerve regeneration after chronic axotomy but not after chronic Schwann cell denervation. Exp Neurol 2002; 175:127-137.
176. Sunderland S. Nerve and Nerve Injuries. Surgery & Hand Surgery. Edinburgh: Churchill Livingstone, 1978; 117-188.
177. Sulaiman OA, Gordon T. Transforming growth factor-beta and forskolin attenuate the adverse effects of long-term Schwann cell denervation on peripheral nerve regeneration in vivo. Glia 2002; 37:206-218.
178. Li H, Terenghi G, Hall SM. Effects of delayed re-innervation on the expression of c-erbB receptors by chronically denervated rat Schwann cells in vivo. Glia 1997; 20:333-347.
179. Dedkov EI, et al. Survival of Schwann cells in chronically denervated skeletal muscles, Acta Neuropathol (Berl) 2002; 103:565-574.
180. Fu SY, Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 1997; 14:67-116.
181. Al-Majed AA, et al. Brief electrical stimulation promotes the speed and accuracy of motor axonal regeneration. J Neurosci 2000; 20:2602-2608.
182. Brushart TM, et al. Electrical stimulation promotes motoneuron regeneration without increasing its speed or conditioning the neuron. J Neurosci 2002; 22:6631-6638.
183. Al Majed AA, Brushart TM, Gordon T. Electrical stimulation accelerates and increases expression of BDNF and trkB mRNA in regenerating rat femoral motoneurons. Eur J Neurosci 2000; 12:4381-4390.
184. Zafra F, et al. Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors. EMBO J 1990; 9:3545-3550.
185. Lu B, Figurov A. Role of neurotrophins in synapse development and plasticity. Rev Neurosci 1997; 8:1-12.
186. Bender RA, et al. Enhanced CREB phosphorylation in immature dentate gyrus granule cells precedes neurotrophin expression and indicates a specific role of CREB in granule cell differentiation. Eur J Neurosci 2001; 13:679-686.
187. Tong L, et al. Effects of exercise on gene-expression profile in the rat hippocampus. Neurobiol Dis 2001; 8:1046-1056.
188. Al-Majed AA, Tam SL, Gordon T. Concurrent induction of tubulin and GAP-43 mRNA and downregulation of neurofilament mRNA in axotomized femoral motoneurons in response to conditioning electrical stimulation. Mol Cell Neurobiol 2004; (in press).
189. Blesch A, Lu P, Tuszynski MH. Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair. Brain Res Bull 2002; 57:833-838.
190. Uittenbogaard M, Martinka DL, Chiaramello A. The basic helixloop-helix differentiation factor Nex1/MATH-2 functions as a key activator of the GAP-43 gene. J Neurochem 2003; 84:678688.
191. Bracken MB, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury, Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997; 277:1597-1604.
192. Bracken MB, Holford TR. Neurological and functional status 1 year after acute spinal cord injury: estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III. J Neurosurg 2002; 96:259-266.
193. Hurlbert RJ, Moulton R. Why do you prescribe methylprednisolone for acute spinal cord injury? A Canadian perspective and a position statement. Can J Neurol Sci 2002; 29:236-239.
194. Hauben E, Schwartz M. Therapeutic vaccination for spinal cord injury: helping the body to cure itself, Trends Pharmacol Sci 2003; 24:7-12.
195. Popovich PG, Jones TB. Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol Sci 2003; 24:13-17.
196. Giulian D, et al. Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system. J Neurosci Res 1993; 36:681-693.
197. Blight AR. Effects of silica on the outcome from experimental spinal cord injury: implication of macrophages in secondary tissue damage, Neuroscience 1994; 60:263-273.
198. Giulian D, Robertson C. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol 1990; 27:33-42.
199. Mabon PJ, Weaver LC, Dekaban GA. Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin alphaD: a potential new anti-inflammatory treatment. Exp Neurol 2000; 166:52-64.
200. Popovich PG, et al. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 1999; 158:351-365.
201. Guth L, et al. Spinal cord injury in the rat: treatment with bacterial lipopolysaccharide and indomethacin enhances cellular repair and locomotor function. Exp Neurol 1994; 126:76-87.
202. Ousman SS, David S. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 2000; 30:92-104.
203. Ousman SS, David S. MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J Neurosci 2001; 21:4649-4656.
204. Fiedler M, et al. An engineered IN-1 F(ab) fragment with improved affinity for the Nogo-A axonal growth inhibitor permits immunochemical detection and shows enhanced neutralizing activity. Protein Eng 2002; 15:931-941.
205. Fournier AE, et al. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin. J Neurosci 2002; 22:8876-8883.
206. GrandPre T, Li S, Strittmatter SM. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 2002; 417:547-551.
207. Song HJ, Ming GL, Poo MM. cAMP-induced switching in turning direction of nerve growth cones, Nature 1997; 388:275-279.
208. Qiu J, et al. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron 2002; 34:895-903.
209. Cai D, Deng, K Mellado W, et al. Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron. 2002 Aug 15;35(4):711-719.
210. Cui Q, et al. Intraocular elevation of cyclic AMP potentiates ciliary neurotrophic factor-induced regeneration of adult rat retinal ganglion cell axons. Mol Cell Neurosci 2003; 22:49-61.
211. Li Y, Decherchi P, Raisman G. Transplantation of olfactory ensheathing cells into spinal cord lesions restores breathing and climbing. J Neurosci 2003; 23:727-731.
212. Ramon-Cueto A, et al. Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J Neurosci 1998; 18:3803-3815.
213. Bradbury EJ, et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002; 416:636-640.
214. Schnell L, et al. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature 1994; 367:170-173.